Antipanic drugs and pulmonary function in panic disorder patients;Medicação antipânico e função pulmonar em pacientes com transtorno de pânico

Revista de Psiquiatria Clinica

Volumn 36, Issue 4, 2009, Pages 123-136

  Nascimento, Isabella ^a,b   De Melo Neto, Valfrido Leão ^a   Valença, Alexandre Martins ^a   Lopes, Fabiana Leão ^a   Freire, Rafael Christophe Da Rocha ^a   Cassabian, Laura Andréa ^a   Garcia, Cristiane Sousa Nascimento Baez ^a   Zin, Walter Araújo ^a   Nardi, Antonio Egidio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Rua Professor Hermes de Lima   (Brazil)

Author keywords

Anxiety disorder; Lung function; Respiration; Salbutamol; Spirometry

Indexed keywords

ANTIPANIC AGENT; CLONAZEPAM; DIAZEPAM; IMIPRAMINE; PAROXETINE; SALBUTAMOL;

ADULT; AIRWAY OBSTRUCTION; ANXIETY; ARTICLE; BRONCHODILATATION; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; PANIC; RATING SCALE; SPIROMETRY;

EID: 70349878982     PISSN: 01016083     EISSN: 1806938X     Source Type: Journal    
DOI: 10.1590/S0101-60832009000400001     Document Type: Article

References (36)

1. Klein DF. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry. 1993; 50(4):306-317
2. Ley R. Dyspneic-fear and catastrophic cognitions in hyperventilatory panic attacks. Behav Res Ther. 1989;27(2):549-554 (Pubitemid 19243467)
3. Papp LA, Klein DF, Gorman JM. Carbon dioxide hypersensitivity, hyperventilation, and panic disorder. Am J Psychiatry. 1993;150(8):1149-1157 (Pubitemid 23218893)
4. Asmundson GJ, Stein MB. A preliminary analysis of pulmonary function in panic disorder: implications for the dyspnea-fear theory. J Anxiety Disord. 1994;8:63-69
5. Stein MB, Millar TW, Larsen DK, Kryger MH. Irregular breathing during sleep in patients with panic disorder. Am J Psychiatry. 1995; 152(8):1168-1173
6. McNally RJ, Hornig CD, Donnell CD. Clinical versus nonclinical panic. A test of suffocation false alarm theory. Behav Res Ther. 1995; 33(2):127-131
7. Vedyasova OA. Respiratory effects of stimulation of the limbic cortex in rats and their modulation with serotonin. Bull Exp Biol Med. 2005;140(3):265-267
8. Perna G, Bertani A, Politi E, Colombo G, Bellodi L. Asthma and panic attacks. Biol Psychiatry. 1997;42(10):625-630
9. Nascimento I, Nardi AE, Valença AM, Lopes FL, Mezzasalma MA, Nascentes R, et al. Psychiatric disorders in asthmatics outpatients. Psychiatry Res. 2002;110(1):73-80.
10. Goodwin RD, Jacobi F, Thefeld W. Mental disorders and asthma in the community. Arch Gen Psychiatry. 2003;60(11):1125-1130
11. Porzelius J, Vest M, Nochomovitz M. Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients. Behav Res Ther. 1992;30(1):75-77
12. Carr RE, Lehrer PM, Hochron SM. Panic symptoms in asthma and panic disorder: a preliminary test of dyspnea-fear theory. Behav Res Ther. 1992;30(3):251-261
13. Carr RE, Lehrer PM, Rausch LL, Hochron SM. Anxiety sensitivity and panic attacks in an asthmatic population. Behav Res Ther. 1994; 32(4):411-418 (Pubitemid 24112762)
14. Van Peski-Oosterbaan AS, Spinhoven P, Van der Does AJ, Willems LN, Sterk PJ. Is there a specific relationship between asthma and panic disorder? Behav Res Ther. 1996;34(4):333-340
15. Perna G, Marconi C, Battaglia M, Bertani A, Panzacchi A, Bellodi L. Subclinical impairment of lung airways in patients with panic disorder. Biol Psychiatry. 1994;36(9):601-605 (Pubitemid 24352007)
16. Verburg K, de Leeuw M, Pols H, Griez E. No dynamic lung function abnormalities in panic disorder patients. Biol Psychiatry. 1997;41(7):834-836
17. Carr RE, Lehrer PM, Hochron SM, Jackson A. Effect of psychological stress on airway impedance in individuals with asthma and panic disorder. J Abnor Psychol. 1996;105(1):137-141 (Pubitemid 26039300)
18. Olsson M, Annerbrink K, Bengtsson F, Hedner J, Eriksson E. Paroxetine influences respiration in rats: implications for the treatment of panic disorder. Eur Neuropsychopharmacol. 2004;14(1):29-37. (Pubitemid 37495028)
19. Perez JF, Sanderson MJ. The contraction of smooth muscle cells of intrapulmonary arterioles is determined by the frequency of Ca2+ oscillations induced by 5-HT and KCl. J Gen Physiol. 2005;125(6):555-567 (Pubitemid 40994115)
20. Yeragani VK, Rao R, Tancer M, Uhde T. Paroxetine decreases respiratory irregularity of linear and nonlinear measures of respiration in patients with panic disorder. A preliminary report. Neuropsychobiology. 2004;49(2):53-57
21. First MB, Spitzer RL, Gibbon M, Williams JBM. Structured Clinical Interview Diagnostic (SCID) for DSM IV axis I Disorders - Clinician Version (SCID-CV). Washington: American Psychiatric Press; 1997.
22. th ed. Washington: American Psychiatric Press; 1994.
23. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144(5):1202-1218
24. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983;127(6):725-734
25. Beck P, Kastrup M, Rafaelsen OJ. Mini-compendium of rating scales of anxiety, depression, mania, schizophrenia with corresponding DSM III syndromes. Acta Psychiatr Scand Suppl. 1986;326:1-37.
26. Boulet LP. Asymptomatic airway hyperresponsiveness. A curiosity or an opportunity to prevent asthma? Am J Respir Crit Care Med. 2003;167(3):371-378
27. Papp LA, Weiss JR, Greenberg HE, Rifking A, Scharf SM, Gorman JM, et al. Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. Am J Psychiatry. 1995;152(10):1531.
28. Smoller JW, Pollack MH, Systrom D, Kradin RL. Sertraline effects in dyspnea, in patients with obstructive airways disease. Psychosomatics.1998;39(1) :24-29 (Pubitemid 28152594)
29. Lechin F, van der Dijs B, Orozco B, Jara H, Rada I, Lechin ME, et al. The serotonin uptake-enhancing drug tianeptine suppresses asthmatic symptoms in children: a double-blind, crossover, placebo-controlled study. J Clin Pharmacol. 1998;38(10):918-925
30. Lechin F, van der Dijs B, Lechin AE. Severe asthma and plasma serotonin. Allergy. 2002;57(3):258-259
31. Nardi AE, Perna G. Clonazepam in psychiatric disorders: an update. Int Clin Psychopharmacol. 2006;21(3):131-142
32. Clark DM. A cognitive approach to panic. Behav Res Ther. 1986;24(4): 461-470
33. Chambless DL, Caputo GC, Bright P, Gallagher R. Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol. 1984;52(6):1090-1097 (Pubitemid 15082536)
34. Peterson RA, Reiss S. The manual for the Anxiety Sensitivity Index. Worthington: International Diagnostic System; 1987.
35. Romano P, van Beek N, Cucchi M, Biff S, Perna G. Anxiety sensitivity and modulation of the serotonergic system in patients with PD. J Anxiety Disord. 2004;18(3):423-431 (Pubitemid 38569724)
36. Clark DM, Salkovski PM, Hackmann A, Middleton H, Anastasiades P, Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of PD. Br J Psychiatry. 1994;164(6): 759-769